LobbyingBurrell International Group lobbying by quarter
Burrell International Group's latest lobbying report covers Q2 2024, at under $5,000. Its first report covers Q2 2023; the issues it reports most are Medical/Disease Research/Clinical Labs.
Burrell International Group
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q2 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2023 | $5,000 | 1 |
| Q3 2023 | $10K | 1 |
| Q4 2023 | $10K | 1 |
| Q1 2024 | $5,000 | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 0 |
| Q4 2024 | $0 | 0 |
| Q1 2025 | $0 | 0 |
| Q2 2025 | $0 | 0 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Medical research and clinical labs4 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES4 reports
- SENATE4 reports
Firms it paid
| Firm | ||
|---|---|---|
| Trusynergy | $30K | 5 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 24/07/18for Q2 2024 | Trusynergy | Under $5,000 |
| 24/04/10for Q1 2024 | Trusynergy | $5,000 |
| 24/01/22for Q4 2023 | Trusynergy | $10K |
| 23/10/15for Q3 2023 | Trusynergy | $10K |
| 23/07/18for Q2 2023 | Trusynergy | $5,000 |
| 23/07/18for Q2 2023 | Trusynergy | Under $5,000 |